MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Efficacy of liquid sinemet on non-motor symptoms in Parkinson’s disease

    M. Danoudis, R. Iansek, C. Boon (Cheltenham, Australia)

    Objective: To investigate the short term effect of liquid sinemet on the non-motor symptoms of people with advanced Parkinson’ disease (PD) who experience complex motor…
  • 2018 International Congress

    Effects of neural stem cell transplantation on the differentiation of dopaminergic neurons in the substantia nigra and changes to rotational behavior of Parkinson’s disease rats

    J.J. Xiao, X.P. Wang (Shanghai, China)

    Objective: To explore the effects of neural stem cells transplantation on the differentiation of substantia nigra dopaminergic neurons and on the rotational behavior in a…
  • 2018 International Congress

    B lymphocytes may be protective in early Parkinson’s disease and in an animal model of dopaminergic cell death

    K. Scott, C. Williams-Gray, R. Wijeyekoon, S. Hayat, K. Hall, P. Tyers, R. Mathews, R. Barker, M. Clatworthy (Cambridge, United Kingdom)

    Objective: To investigate B lymphocyte phenotype and function in human PD and in an animal model of disease. Background: The clinical course in Parkinson’s disease…
  • 2018 International Congress

    Insulin degrading enzyme, a novel key protein against alpha-synuclein oligomers formation?

    I. Martinez-Valbuena, R. Valenti-Azcarate, I. Amat-Villegas, I. Marcilla-Garcia, L. Alonso-Herrero, M. Carmona-Abellan, G. Marti-Andres, MT. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this work is to study the interaction between α-synuclein and the insulin degrading enzyme in the pancreas of subjects with synucleinopathies.…
  • 2018 International Congress

    Freezing of Gait in Parkinson’s Disease: Clinico-biochemical Observations

    B. Mondal, R. Banerjee, K. Chatterjee, A. Roy, S. Shubham, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: We aimed to compare motor and non-motor functions, 2D-spatiotemporal gait parameters and serum oxidative markers including catalase (CAT), superoxide dismutase (SOD) and malondialdehyde (MDA)…
  • 2018 International Congress

    Effects of Glial Heme Oxygenase-1 on Neuronal Alpha-Synuclein in the GFAP.HMOX1 Mouse Model of Parkinson’s Disease

    M. Cressatti, W. Song, A. Turk, C. Galindez, H. Schipper (Montreal, QC, Canada)

    Objective: To determine whether astroglial HO-1 transduces environmental and endogenous stressors into patterns of neural damage which promote the toxicity of neuronal alpha-synuclein. Background: The…
  • 2018 International Congress

    Classification of Dopaminergic-State and Motor Activity by Theta, Beta and Gamma Activity in Parkinson’s Disease

    I. Weber, C. Oehrn, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)

    Objective: To test whether machine learning algorithms are suitable to classify dopamine and behavioral states in Parkinson’s patients (PD). Background: While motor symptoms of PD…
  • 2018 International Congress

    Evaluation of affective temperament and bipolarity among patients with Parkinson’ s disease

    Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)

    Objective: To compare the bipolarity and affective temperament scores between patients with Parkinson’s Disease (PD) and healthy controls. Background: Mood disorders are the most common…
  • 2018 International Congress

    Evaluation of impulsivity in Parkinson’ s disease

    Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)

    Objective: To evaluate the impulsivity in patients with Parkinson’s Disease. Background: Parkinson’s disease (PD) is a chronic, neurodegenerative, progressive disease characterized with cardinal motor symptoms…
  • 2018 International Congress

    Depression, apathy, fatigue in Parkinson with or without STN DBS

    L. Al-Nakeeb, M. Panisset (Montreal, QC, Canada)

    Objective: To determine the prevalence of depression, evaluate the relationship between depression, apathy and fatigue, and the impact of STN DBS on the same symptoms.…
  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley